DCM
MD icon

Delpha Capital Management’s Pediatrix Medical MD Stock Holding History

Delpha Capital Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-550
Closed -$29K – 768
2017
Q4 		$29K Buy
+550
New +$25.9K 0.03% 583

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Delpha Capital Management's MD Position: Q1 2018 in Review

Delpha Capital Management sold out of Pediatrix Medical (MD) in Q1 2018, closing a stake of 550 shares — an estimated $29K sold.

Delpha Capital Management first reported a position in MD in Q4 2017 and held it in 1 quarter. The position peaked at $29K in Q4 2017. 342 funds tracked by Wall St. Rank hold MD as of Q1 2018.

  • Delpha Capital Management reported no remaining Pediatrix Medical position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 550 Pediatrix Medical shares in Q1 2018, an estimated $29K.
  • Delpha Capital Management first reported a position in Pediatrix Medical in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Pediatrix Medical position peaked at $29K in Q4 2017.
  • 342 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.